Nu-Med Plus Inc. (NUMD) to Present at National Investment Banking Association (NIBA) Conference
Nu-Med Plus (OTC: NUMD) designs technology for the safe and precise delivery of nitric oxide dosages. This naturally occurring molecule works to effectively dilate constricted blood vessels. The Nu-Med Plus patented technology can be used to benefit heart patients and treat respiratory complications in newborns. Furthermore, scientists of Nu-Med Plus continue to explore the possibilities of their nitric-oxide technologies to treat wound care and benefit those with COPD, ARDS, malaria and tuberculosis. Its nitric oxide delivery device was designed for use in the neonatal intensive care unit (NICU) and is set to be delivered by the conclusion of 2019. For…







